Abstract
Three hundred and forty-four patients with operable colorectal adenocarcinoma, Dukes' stage B or C, were entered into a randomized controlled trial of intraoperative and postoperative intravenous urokinase and/or long-term sodium warfarin therapy. The factorial design of the trial allowed evaluation of each therapy separaetely. Age, sex, Dukes' stage and cancer site were similar in the treatment groups. Using life-table methods, survival and recurrence/metastases free survival were estimated up to 6 years postoperatively. No significant effects of either therapy on these endpoints were found.
Similar content being viewed by others
References
Clery, A. P., Hogan, B. L., Holland, P. D. J., Widdess, J. D. H., Ryan, M., Doyle, J. S., 1972, Early experience in a controlled clinical trial using streptokinase induced fibrinolysus during resections for colon and rectal carcinomas in an attempt to prevent haematogenous metastasis.Journal of the Irish College of Physicians and Surgeons,1, 91–95.
Cox, D. R., 1972, Regression models and life-tables (with discussion).Journal of the Royal Statistical Association, B34, 187–220.
George, S. L., andDesu, M. M., 1974, Planning the size and duration of a clinical trial studying the time to some critical event.Journal of Chronic Diseases,27, 15–24.
Hilgard, P., andThornes, R. D., 1976, Anticoagulants in the treatment of cancer.European Journal of Cancer,12, 755–762.
Kaplan, E. L., andMeier, P., 1958, Nonparametric estimation from incomplete observations.Journal of the American Statistical Association,53, 457–481.
Kohanna, F. H., Sweeney, J., Hussey, S., Zacharski, L. R., andSalzman, E. W., 1983, Effect of perioperative low-dose heparin administration on the course of colon cancer.Surgery,93, 433–438.
Maat, B., 1980, Selective macrophage inhibition abolishes warfarin-induced reduction of metastases.British Journal of Cancer,41, 313–316.
Pasternack, B. S., andGilbert, H. S., 1971, Planning the duration of long-term survival time studies designed for accrual by cohorts.Journal of Chronic Diseases,24, 681–700.
Peto, R., Pike, M. C., Armitage, P., Brelson, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Pete, J., andSmith, P. G., 1977, Design and analysis of randomized clinical trials requiring prolonged observation of each patient II Analysis and examples.British Journal of Cancer,35, 1–39.
Salsbury, A. J., 1975, The significance of the circulating cancer cell.Cancer Treatment Reviews,2, 55–72.
Thornes, R. D., 1967, Fibrinogen and the interstitial behaviour of cancer.Endogenous Factors Influencing Host-Tumour Balance, edited by R. W. Wissler, T. L. Dao and S. Wood Jr. (Chicago and London: University of Chicago Press), pp. 255–266.
Thornes, D., Daly, L., Lynch, G., Thornes, D., Daly, L., Lynch, G., Browne, H., Tanner, A., Keane, F., O'Loughlin, S., Corrigan, T., Daly, P., Edwards, G., Breslin, B., Browne, Hy., Shine, M., Lennon, F., Hanley, J., McMurray, N., andGaffney, E., 1989, prevention of early recurrence of high risk malignant melanoma by coumarin.European Journal of Surgical Oncology,15, 431–435.
Törngren, S., andRieger, A., 1983, The influence of heparin and curable resection on the survival of colorectal cancer.Acta Chirurgica Scandinavica,149, 427–429.
White, H., andGriffiths, J. D., 1976, Circulating malignant cells and fibrinolysis during resection of colorectal cancer.Proceedings of the Royal Society for Medicine,69, 467–469.
Wood, S. Jr, Holyoke, E. D., andYardley, J. H., 1961, Mechanisms of metastasis production from blood-borne cancer cells.Canadian Cancer Conference,4, 167–223.
Wojtukiewicz, M. Z., Zacharski, L. R., Memoli, V. A., Kisiel, W., Kudryk, B. J., Rousseau, S. M., andStump, D. C., 1989, Indirect activation of blood coagulation in colon cancer.Thrombosis and Haemostasis,62, 1062–1066.
Zacharski, L. R., Henderson, W. G., Rickless, F. R., Forman, W. B., Cornell, C. J., Forcier, R. J., Edwards, R. L., Headley, E., Kim, S. H., O'Donnell, J. F., O'Dell, R., Tornyds, K., andKwaan, H. C., 1984, Effect of Warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate: final report of VA cooperative Study.Cancer,53, 2046–2052.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Daly, L. The first international urokinase/warfarin trial in colorectal cancer. Clin Exp Metast 9, 3–11 (1991). https://doi.org/10.1007/BF01831705
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01831705